We are live on ! Find out more
VMI

VHCP Management II Portfolio holdings

AUM $379M
1-Year Est. Return 421.62%
This Fund
S&P 500
This Quarter Est. Return
+255.77%
1 Year Est. Return
+421.62%
3 Year Est. Return
+2,333.62%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$379M
AUM Growth
+$117M
Cap. Flow
-$59M
Cap. Flow %
-15.54%
Top 10 Hldgs %
94.12%
Holding
29
New
8
Increased
1
Reduced
7
Closed
9

Top Buys

Rank Stock Value
1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$22.3M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$3.59M
3
RLMD icon
Relmada Therapeutics
RLMD
+$3.49M
4
ADVM
Adverum Biotechnologies
ADVM
+$3.38M
5
MRSN
Mersana Therapeutics
MRSN
+$2.7M

Top Sells

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$22.6M
2
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$16M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$13.2M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$12.4M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$8.24M

Sector Composition

Rank Sector Weight
1 Healthcare 99.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
26
DELISTED
Radius Health, Inc.
RDUS
– –
-13,667
Closed -$352K
PRVL
27
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
– –
-2,604
Closed -$32K
RARX
28
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-677,164
Closed -$16M
LJPC
29
DELISTED
La Jolla Pharmaceutical Company
LJPC
– –
-518,102
Closed -$4.56M
1
2

Similar funds

ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
PI
PHH Investments Addison, Texas $378M AUM 19.74% 1-Year Est. Return
SC
Southside Capital Miami Beach, Florida $382M AUM 30.29% 1-Year Est. Return
FFSOTS
Fiduciary Financial Services of The Southwest Dallas, Texas $382M AUM 25.98% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
WC
Whitnell & Co Oak Brook, Illinois $326M AUM 25.97% 1-Year Est. Return
VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
LB
Landmark Bank Columbia, Missouri $444M AUM 30.12% 1-Year Est. Return

VHCP Management II's Q4 2019 Portfolio in Review

As of Q4 2019, VHCP Management II held 29 positions worth $379M, up 45% from $262M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

VHCP Management II withdrew a net $59M in Q4 2019, closing 9 positions and reducing 7 holdings. Its most notable exit was Ascendis Pharma A/S, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 98% a quarter earlier.

Against the trend, VHCP Management II opened a new position in IVERIC bio, Inc. Common Stock worth $8.62M.

  • VHCP Management II's largest Q4 2019 buy was IVERIC bio, Inc. Common Stock: 1,004,299 shares worth $8.62M.
  • VHCP Management II added most to Constellation Pharmaceuticals, Inc. in Q4 2019, an estimated $22.3M increase.
  • VHCP Management II's biggest Q4 2019 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $13.2M.
  • VHCP Management II fully exited Ascendis Pharma A/S in Q4 2019, selling an estimated $22.6M.
  • VHCP Management II's ten largest holdings make up 94% of its $379M portfolio in Q4 2019.
  • VHCP Management II opened 8 new positions and closed 9 in Q4 2019.
  • VHCP Management II's portfolio value rose 45% quarter-over-quarter to $379M.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.